218 related articles for article (PubMed ID: 37459583)
41. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
42. Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS).
Gramatges MM; Morton LM; Yasui Y; Arnold MA; Neglia JP; Leisenring WM; Machiela MJ; Dagnall CL; Chanock SJ; Armstrong GT; Robison LL; Bhatia S; Lupo PJ
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):417-419. PubMed ID: 30377209
[TBL] [Abstract][Full Text] [Related]
43. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
[TBL] [Abstract][Full Text] [Related]
44. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide Association Studies Reveal Novel Locus With Sex-/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors.
Im C; Li N; Moon W; Liu Q; Morton LM; Leisenring WM; Howell RM; Chow EJ; Sklar CA; Wilson CL; Wang Z; Sapkota Y; Chemaitilly W; Ness KK; Hudson MM; Robison LL; Bhatia S; Armstrong GT; Yasui Y
J Bone Miner Res; 2021 Apr; 36(4):685-695. PubMed ID: 33338273
[TBL] [Abstract][Full Text] [Related]
46. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
47. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
Bhakta N; Liu Q; Ness KK; Baassiri M; Eissa H; Yeo F; Chemaitilly W; Ehrhardt MJ; Bass J; Bishop MW; Shelton K; Lu L; Huang S; Li Z; Caron E; Lanctot J; Howell C; Folse T; Joshi V; Green DM; Mulrooney DA; Armstrong GT; Krull KR; Brinkman TM; Khan RB; Srivastava DK; Hudson MM; Yasui Y; Robison LL
Lancet; 2017 Dec; 390(10112):2569-2582. PubMed ID: 28890157
[TBL] [Abstract][Full Text] [Related]
48. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
49. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
Henderson TO; Whitton J; Stovall M; Mertens AC; Mitby P; Friedman D; Strong LC; Hammond S; Neglia JP; Meadows AT; Robison L; Diller L
J Natl Cancer Inst; 2007 Feb; 99(4):300-8. PubMed ID: 17312307
[TBL] [Abstract][Full Text] [Related]
50. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.
Dixon SB; Chen Y; Yasui Y; Pui CH; Hunger SP; Silverman LB; Ness KK; Green DM; Howell RM; Leisenring WM; Kadan-Lottick NS; Krull KR; Oeffinger KC; Neglia JP; Mertens AC; Hudson MM; Robison LL; Armstrong GT; Nathan PC
J Clin Oncol; 2020 Oct; 38(29):3418-3429. PubMed ID: 32706634
[TBL] [Abstract][Full Text] [Related]
51. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
52. Generalizability of "GWAS Hits" in Clinical Populations: Lessons from Childhood Cancer Survivors.
Im C; Qin N; Wang Z; Qiu W; Howell CR; Sapkota Y; Moon W; Chemaitilly W; Gibson TM; Mulrooney DA; Ness KK; Wilson CL; Morton LM; Armstrong GT; Bhatia S; Zhang J; Hudson MM; Robison LL; Yasui Y
Am J Hum Genet; 2020 Oct; 107(4):636-653. PubMed ID: 32946765
[TBL] [Abstract][Full Text] [Related]
53. Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy.
Tsui K; Gajjar A; Li C; Srivastava D; Broniscer A; Wetmore C; Kun LE; Merchant TE; Ellison DW; Orr BA; Boop FA; Klimo P; Ross J; Robison LL; Armstrong GT
Neuro Oncol; 2015 Mar; 17(3):448-56. PubMed ID: 25395462
[TBL] [Abstract][Full Text] [Related]
54. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study.
Termuhlen AM; Tersak JM; Liu Q; Yasui Y; Stovall M; Weathers R; Deutsch M; Sklar CA; Oeffinger KC; Armstrong G; Robison LL; Green DM
Pediatr Blood Cancer; 2011 Dec; 57(7):1210-6. PubMed ID: 21384541
[TBL] [Abstract][Full Text] [Related]
55. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort.
Trama A; Tittarelli A; Barigelletti G; Botta L; Gatta G; Tagliabue G; Contiero P; Guzzinati S; Andreano A; Manneschi G; Falcini F; Castaing M; Filiberti RA; Gasparotti C; Cirilli C; Mazzucco W; Mangone L; Iacovacci S; Vitale MF; Stracci F; Piffer S; Tumino R; Carone S; Sampietro G; Melcarne A; Ballotari P; Boschetti L; Pisani S; Cavalieri D'Oro L; Cuccaro F; D'Argenzio A; D'Orsi G; Fanetti AC; Ardizzone A; Candela G; Savoia F; Pascucci C; Castelli M; Storchi C; Bernasconi A
Cancer; 2022 Jan; 128(2):364-372. PubMed ID: 34582036
[TBL] [Abstract][Full Text] [Related]
56. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
57. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
58. Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer.
Wu NL; Chen Y; Dieffenbach BV; Ehrhardt MJ; Hingorani S; Howell RM; Jefferies JL; Mulrooney DA; Oeffinger KC; Robison LL; Weil BR; Yuan Y; Yasui Y; Hudson MM; Leisenring WM; Armstrong GT; Chow EJ
J Clin Oncol; 2023 Apr; 41(12):2258-2268. PubMed ID: 36795981
[TBL] [Abstract][Full Text] [Related]
59. Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
Moskowitz CS; Chou JF; Neglia JP; Partridge AH; Howell RM; Diller LR; Novetsky Friedman D; Barnea D; Morton LM; Turcotte LM; Arnold MA; Leisenring WM; Armstrong GT; Robison LL; Oeffinger KC; Henderson TO
J Clin Oncol; 2019 Aug; 37(24):2120-2130. PubMed ID: 31260644
[TBL] [Abstract][Full Text] [Related]
60. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
